Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-001412
Filing Date
2025-02-14
Accepted
2025-02-14 08:18:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8345
  Complete submission text file 0001085146-25-001412.txt   10129
Mailing Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019
Business Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

EIN.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address GOTTLIEB-DAIMLER-STRASSE 2 MANNHEIM 2M 68165
Business Address GOTTLIEB-DAIMLER-STRASSE 2 MANNHEIM 2M 68165 49-621-560030
Affimed N.V. (Subject) CIK: 0001608390 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88320 | Film No.: 25623403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)